HomeRAPT • NASDAQ
add
Rapt Therapeutics Inc
Previous close
$34.47
Day range
$33.90 - $35.72
Year range
$5.67 - $42.39
Market cap
955.06M USD
Avg Volume
454.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.37M | -2.11% |
Net income | -17.58M | 4.62% |
Net profit margin | — | — |
Earnings per share | -0.65 | 82.71% |
EBITDA | -19.17M | 1.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 157.34M | 60.71% |
Total assets | 165.74M | 52.80% |
Total liabilities | 13.76M | 6.20% |
Total equity | 151.98M | — |
Shares outstanding | 27.71M | — |
Price to book | 3.82 | — |
Return on assets | -28.14% | — |
Return on capital | -30.07% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -17.58M | 4.62% |
Cash from operations | -12.46M | 29.30% |
Cash from investing | 8.47M | -54.10% |
Cash from financing | 36.00K | — |
Net change in cash | -3.96M | -580.68% |
Free cash flow | -6.33M | 42.17% |
About
Founded
2015
Headquarters
Website
Employees
60
